(Q37864705)

24 August 2017

1 reference

title

Biomarkers of therapy responsiveness in asthma: pitfalls and promises (English)

1 reference

24 August 2017

0 references

0 references

2

1 reference

24 August 2017

S J H Vijverberg

1

1 reference

24 August 2017

E S Koster

3

1 reference

24 August 2017

C K van der Ent

4

1 reference

24 August 2017

J A M Raaijmakers

5

1 reference

24 August 2017

A-H Maitland-van der Zee

6

1 reference

24 August 2017

publication date

1 May 2011

1 reference

Clinical & Experimental Allergy

24 August 2017

published in

1 reference

24 August 2017

volume

41

1 reference

24 August 2017

issue

5

1 reference

24 August 2017

page(s)

615-629

1 reference

Anti-inflammatory drug therapy in asthma

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

Heterogeneity of therapeutic responses in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

Quality of life in children with undiagnosed and diagnosed asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

Difficult to control asthma in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

Immunology of asthma and chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

Inflammatory subtypes in asthma are related to airway hyperresponsiveness to mannitol and exhaled NO.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

Eosinophilic airway inflammation and the prognosis of childhood asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

Neutrophilic airway inflammation is a main feature of induced sputum in nonatopic asthmatic children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

Phenotypic differences between pediatric and adult asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

Effects of steroid therapy on inflammatory cell subtypes in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

Regulation of inflammatory cell function by corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

Mepolizumab and exacerbations of refractory eosinophilic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

Mepolizumab for prednisone-dependent asthma with sputum eosinophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

Genetic predictors of response to therapy in childhood asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

Adrenergic beta(2)-receptor genotype predisposes to exacerbations in steroid-treated asthmatic patients taking frequent albuterol or salmeterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

beta-Adrenergic receptor polymorphisms and response to salmeterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

Novel insights into mechanisms of glucocorticoid action and the development of new glucocorticoid receptor ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

Pharmacogenetic study of the effects of NK2R G231E G>A and TBX21 H33Q C>G polymorphisms on asthma control with inhaled corticosteroid treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

Dual-specificity phosphatase 1 as a pharmacogenetic modifier of inhaled steroid response among asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

The glucocorticoid receptor heterocomplex gene STIP1 is associated with improved lung function in asthmatic subjects treated with inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

Profiling of genes expressed in peripheral blood mononuclear cells predicts glucocorticoid sensitivity in asthma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

Use of gene expression profiling to identify a novel glucocorticoid sensitivity determining gene, BMPRII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

Systems biology in pharmacogenomic research: the way to personalized prescribing?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

Characterization of within-subject responses to fluticasone and montelukast in childhood asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

Accuracy of eosinophils and eosinophil cationic protein to predict steroid improvement in asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

The molecular phenotype of severe asthma in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

Expression of activated Fc gamma RII discriminates between multiple granulocyte-priming phenotypes in peripheral blood of allergic asthmatic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

Non-eosinophilic cor ticosteroid unresponsive asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

Significant variability in response to inhaled corticosteroids for persistent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

The Predicting Response to Inhaled Corticosteroid Efficacy (PRICE) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

Assessment and evaluation of symptomatic steroid-naive asthmatics without sputum eosinophilia and their response to inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

Non-invasive markers of airway inflammation as predictors of oral steroid responsiveness in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

Low sputum eosinophils predict the lack of response to beclomethasone in symptomatic asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

Urinary leukotriene E4/exhaled nitric oxide ratio and montelukast response in childhood asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

Exhaled breath condensate and airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

Biochemical markers as a response guide for steroid therapy in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

Eotaxin-1 in exhaled breath condensate of stable and unstable asthma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

Increased macrophage-derived chemokine in exhaled breath condensate and plasma from children with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

Exhaled nitric oxide in the diagnosis and management of childhood asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

Prospective evaluation of the validity of exhaled nitric oxide for the diagnosis of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

Heterogeneity of FeNO response to inhaled steroid in asthmatic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

Exhaled nitric oxide in pregnant healthy and asthmatic women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

Effect of montelukast on exhaled NO in asthmatic children exposed to relevant allergens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

Exhaled NO and eosinophil markers in blood, nasal lavage and sputum in children with asthma after withdrawal of budesonide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

Ciclesonide improves measures of small airway involvement in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

Rapid effect of inhaled ciclesonide in asthma: a randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in mild to moderately severe asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

Sputum eosinophil apoptotic rate is positively correlated to exhaled nitric oxide in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

Correlations between exhaled nitric oxide levels, blood eosinophilia, and airway obstruction reversibility in childhood asthma are detectable only in atopic individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

Relationship between exhaled NO, respiratory symptoms, lung function, bronchial hyperresponsiveness, and blood eosinophilia in school children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

Exhaled nitric oxide in a population-based study of asthma and allergy in schoolchildren

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

Influence of atopy and asthma on exhaled nitric oxide in an unselected birth cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

The effect of spirometry and exercise on exhaled nitric oxide in asthmatic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

Use of exhaled nitric oxide measurements to guide treatment in chronic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

Phenotypic predictors of long-term response to inhaled corticosteroid and leukotriene modifier therapies in pediatric asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

An electronic nose in the discrimination of patients with asthma and controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

Increased bronchial nitric oxide production in patients with asthma measured with a novel method of different exhalation flow rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

Functional antagonism by GM-CSF on TNF-α-induced CD83 expression in human neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2011.03694.X

10.1111/J.1365-2222.2011.03694.X

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference